menu ☰
menu ˟

[Comment] 17 and 23: prime numbers for ankylosing spondylitis?

23 Nov 2013

Treatment options for patients with ankylosing spondylitis have improved considerably over the past decade with the availability of tumour necrosis factor-α (TNF)-inhibitors. Traditional disease-modifying anti-rheumatic drugs such as methotrexate that are effective in rheumatoid arthritis have no proven benefit for spinal inflammatory arthritis, the hallmark of ankylosing spondylitis. TNF-inhibitors are often recommended when first-line therapy with non-steroidal anti-inflammatory drugs does not control disease activity, and are effective at reducing inflammation and symptoms of spinal pain and stiffness and improving function in most patients.

23 November 2013

Click here to view the full article which appeared in The Lancet